Format

Send to

Choose Destination
Ann Oncol. 2014 Oct;25(10):1871-88. doi: 10.1093/annonc/mdu385. Epub 2014 Sep 18.

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†.

Author information

1
European School of Oncology & Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal fatimacardoso@fundacaochampalimaud.pt.
2
European School of Oncology, Milan, Italy European School of Oncology, Bellinzona, Switzerland.
3
Breast Cancer Program, Memorial Sloan-Kettering Cancer Centre, New York, USA.
4
Department of Oncology and Radiotherapy, Medical University of Gdansk, Gdansk, Poland.
5
Division of Oncology, Institut Multidisciplinaire d'Oncologie, Genolier, Switzerland.
6
Department of Medical Oncology, Gustave-Roussy Institute, Villejuif, France.
7
Department of Medicine, PUCRS School of Medicine, Porto Alegre, Brazil.
8
Department of Oncology/Radiumhemmet, Karolinska Institutet & Cancer Center Karolinska and Karolinska University Hospital, Stockholm, Sweden.
9
Department of Medical Oncology, Sandro Pitigliani Oncology Centre, Prato, Italy.
10
Breast Cancer Clinical Program, Duke Cancer Institute, Durham, USA.
11
Breast Unit, Champalimaud Cancer Center, Lisbon, Portugal.
12
University Clinic Golnik, Medical Faculty Ljubljana, Ljubljana, Slovenia.
13
NK Basile Cancer Institute Breast Center of Excellence, American University of Beirut Medical Center, Beirut, Lebanon.
14
Brighton & Sussex Medical School, University of Sussex, Falmer, UK.
15
Breast Care Support Group, Europa Donna Malta, Mtarfa, Malta.
16
Division of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, Australia.
17
BC Cancer Agency, Vancouver, Canada.
18
Departments of Health Services Research and Breast Medical Oncology, UT MD Anderson Cancer Center, Houston, USA.
19
APHP Tenon, IUC-UPMC, Francilian Breast Intergroup, AROME, Paris, France.
20
Program of Breast Health, European Institute of Oncology, Milan, Italy.
21
Brustzentrum der Universität München, Munich, Denmark.
22
Screening and Test Evaluation Program, School of Public Health, Sydney Medical School, University of Sydney, Sydney, Australia.
23
Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center, New York, USA.
24
Sheba Medical Center, Tel Hashomer, Israel.
25
Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.
26
Europa Donna Cyprus, Nicosa, Cyprus.
27
AdvancedBC.org, New York.
28
University of Michigan Medical School and School of Public Health, Ann Arbor, USA.
29
Europa Donna Sweden & Bröstcancerföreningarnas Riksorganisation, BRO, Sundbyberg, Sweden.
30
Oncology Institute of Southern Switzerland and Breast Unit of Southern Switzerland, Bellinzona, Switzerland.
31
Department Medical Oncology, Division of Women's Cancers, Dana-Farber Cancer Institute, Boston, USA.
32
Jean Perrin Centre, Comprehensive Cancer Centre, Clermont Ferrand, France.
33
Department of Medicine, Institut Jules Bordet, Brussels, Belgium.
34
Department of Medicine, Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco.
35
Indiana University Medical CTR, Indianapolis, USA.
36
Department of Gynaecology, Martin-Luther-University Halle-Wittenberg, Halle an der Saale, Germany.
37
Breast Oncology Program, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, USA.
38
Sandton Oncology Centre, Johannesburg, South Africa.
39
Department of Radiotherapy, Clinique des Grangettes, Geneva, Switzerland.
40
Nursing Division, Health Board, Cardiff and Vale University, Cardiff, UK.
41
Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
PMID:
25234545
PMCID:
PMC4176456
DOI:
10.1093/annonc/mdu385
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center